Literature DB >> 6159983

Expression of a subgenomic retroviral messenger RNA.

D W Stacey.   

Abstract

When mRNA for avian retroviral envolope glycoprotein (env) was injected into cells transformed by env-deficient Bryan Rous sarcoma virus, the env deficiency of the injected cells was complemented to allow the release of transforming virus for up to 40 hr. When virus spread within the injected culture was allowed to occur, a second phase of transforming virus production by the injected culture began approximately 2 days following injection, continued for many days and often increased to titers well above those seen soon after injection. The requirement for virus spread, along with the genetic properties of virus released long after injection, supported the hypothesis that the second phase of virus production resulted when injected env mRNA was packaged into virus released by injected cells. When this virus infected other cells within the culture the env mRNA was reverse-transcribed to form a subgenomic, proviral-like molecule able to direct the synthesis of env mRNA. Accordingly, it was shown tht neither DNA nor full genomic viral RNA contaminating injected mRNA preparations could account for the results. Evidence that an mRNA can be reverse-transcribed into an active, proviral-like molecule may be of importance in the relationship between retroviruses and their hosts.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6159983     DOI: 10.1016/0092-8674(80)90444-4

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  17 in total

1.  Frequent segregation of more-defective variants from a Rous sarcoma virus packaging mutant, TK15.

Authors:  M Nishizawa; T Koyama; S Kawai
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

2.  Structure and transforming function of transduced mutant alleles of the chicken c-myc gene.

Authors:  T Patschinsky; H W Jansen; H Blöcker; R Frank; K Bister
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

3.  The LTR, v-src, LTR provirus generated in the mammalian genome by src mRNA reverse transcription and integration.

Authors:  J Bodor; J Svoboda
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

4.  Characterization of a myc-containing retrovirus generated by propagation of an MH2 viral subgenomic RNA.

Authors:  P Martin; C Henry; F Ferre; C Bechade; A Begue; C Calothy; B Debuire; D Stehelin; S Saule
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

Review 5.  Microinjection of somatic cells with micropipettes: comparison with other transfer techniques.

Authors:  J E Celis
Journal:  Biochem J       Date:  1984-10-15       Impact factor: 3.857

6.  Characterization of a Rous sarcoma virus mutant defective in packaging its own genomic RNA: biochemical properties of mutant TK15 and mutant-induced transformants.

Authors:  T Koyama; F Harada; S Kawai
Journal:  J Virol       Date:  1984-07       Impact factor: 5.103

7.  Biological activity of cloned retroviral DNA in microinjected cells.

Authors:  J J Kopchick; G Ju; A M Skalka; D W Stacey
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

8.  Effect of intron size on splicing efficiency in retroviral transcripts.

Authors:  B R Cullen; J J Kopchick; D W Stacey
Journal:  Nucleic Acids Res       Date:  1982-10-11       Impact factor: 16.971

9.  v-src induces clonal sarcomas and rapid metastasis following transduction with a replication-defective retrovirus.

Authors:  A W Stoker; M H Sieweke
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

10.  Dexamethasone-stimulated expression of a proviral copy of mouse mammary tumor virus env mRNA.

Authors:  D L Robertson
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.